Dr. Sahoo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Ewing St
Ste C7
Princeton, NJ 08540Phone+1 609-688-0710Fax+1 609-921-0869
Education & Training
Westchester Medical CenterFellowship, Nephrology, 2005 - 2007
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2002 - 2005
NYIT College Of Osteopathic MedicineClass of 2002
Certifications & Licensure
NJ State License 2003 - 2025
Clinical Trials
- Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis Start of enrollment: 2018 Aug 07
- An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease Start of enrollment: 2018 Dec 07
- Open-label Extension Study of Brazikumab in Crohn's Disease Start of enrollment: 2020 Jan 06
Publications & Presentations
PubMed
- 1 citationsQualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patien...Bruce E Sands, Julian Panés, Brian G Feagan, Hongyan Zhang, Marion L Vetter
Value in Health. 2024-09-01 - 5 citationsEfficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.Silvio Danese, Remo Panaccione, Brian G Feagan, Anita Afzali, David T Rubin
The Lancet. Gastroenterology & Hepatology. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
